Company
Stemtech Corp (STEK)
Standardized SEC financial data for Stemtech Corp — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001511820 · OTC · Wholesale-Drugs, Proprietaries & Druggists' Sundries.
Gross margin
73.8%
Operating margin
-47.2%
Net margin
-74.6%
Revenue growth (YoY)
2.7%
Return on equity
72.1%
Free cash flow
-$601K
Debt / equity
-0.73×
Current ratio
0.10×
Ratios for fiscal year 2024, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Revenue | — | $4.4M | $4.3M | $4.6M | $4.9M | $5.1M |
| Cost of revenue |
Balance sheet
| USD | FY2020 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2K | $133K | $828K | $132K | $114K | $255K |
| Inventory |
Cash flow
| USD | FY2020 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$66K | -$267K | -$1.9M | -$1.2M | -$2.0M | -$601K |
| Capital expenditures |
Get STEK data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/STEK/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/STEK/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"